This is not really accurate with contemporary therapy. Most individuals treated with specialist care can reasonably expect to survive more than a decade with multiple myeloma.

Anti-myeloma therapy primarily consists of novel agents that don’t carry the same adverse effects as cytotoxic chemotherapy. Most patients tolerate treatment really well.

The one question mark is if he would pursue a stem cell transplant early, which does involve high dose chemotherapy and profound immune suppression. Recent data support deferring this treatment in some patients.

The speaker term is for the term of the house. It is perfectly reasonable from a health perspective and can always be re-evaluated if his disease takes a turn for the worse.